Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $2.27 billion. The enterprise value is $1.70 billion.
| Market Cap | 2.27B |
| Enterprise Value | 1.70B |
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025, after market close.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 59.60 million shares outstanding. The number of shares has increased by 17.78% in one year.
| Current Share Class | 59.60M |
| Shares Outstanding | 59.60M |
| Shares Change (YoY) | +17.78% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 86.32% |
| Float | 47.65M |
Valuation Ratios
The trailing PE ratio is 14.20.
| PE Ratio | 14.20 |
| Forward PE | n/a |
| PS Ratio | 7.19 |
| Forward PS | 20.36 |
| PB Ratio | 4.26 |
| P/TBV Ratio | 4.27 |
| P/FCF Ratio | 9.91 |
| P/OCF Ratio | 9.86 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.32, with an EV/FCF ratio of 7.41.
| EV / Earnings | 9.94 |
| EV / Sales | 5.25 |
| EV / EBITDA | 11.32 |
| EV / EBIT | 11.39 |
| EV / FCF | 7.41 |
Financial Position
The company has a current ratio of 10.70, with a Debt / Equity ratio of 0.02.
| Current Ratio | 10.70 |
| Quick Ratio | 10.57 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.05 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 40.97% and return on invested capital (ROIC) is 22.01%.
| Return on Equity (ROE) | 40.97% |
| Return on Assets (ROA) | 19.96% |
| Return on Capital (ROIC) | 22.01% |
| Revenue Per Employee | $2.89M |
| Profits Per Employee | $1.53M |
| Employee Count | 112 |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $2.23 million in taxes.
| Income Tax | 2.23M |
| Effective Tax Rate | 1.29% |
Stock Price Statistics
The stock price has increased by +53.82% in the last 52 weeks. The beta is 2.22, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 2.22 |
| 52-Week Price Change | +53.82% |
| 50-Day Moving Average | 40.93 |
| 200-Day Moving Average | 37.95 |
| Relative Strength Index (RSI) | 46.07 |
| Average Volume (20 Days) | 651,657 |
Short Selling Information
The latest short interest is 3.80 million, so 6.37% of the outstanding shares have been sold short.
| Short Interest | 3.80M |
| Short Previous Month | 3.61M |
| Short % of Shares Out | 6.37% |
| Short % of Float | 7.97% |
| Short Ratio (days to cover) | 5.76 |
Income Statement
In the last 12 months, PTGX had revenue of $323.80 million and earned $170.85 million in profits. Earnings per share was $2.68.
| Revenue | 323.80M |
| Gross Profit | 323.80M |
| Operating Income | 149.11M |
| Pretax Income | 172.60M |
| Net Income | 170.85M |
| EBITDA | 150.07M |
| EBIT | 149.11M |
| Earnings Per Share (EPS) | $2.68 |
Balance Sheet
The company has $468.72 million in cash and $10.90 million in debt, giving a net cash position of $572.38 million or $9.60 per share.
| Cash & Cash Equivalents | 468.72M |
| Total Debt | 10.90M |
| Net Cash | 572.38M |
| Net Cash Per Share | $9.60 |
| Equity (Book Value) | 531.92M |
| Book Value Per Share | 8.94 |
| Working Capital | 432.19M |
Cash Flow
In the last 12 months, operating cash flow was $230.29 million and capital expenditures -$1.06 million, giving a free cash flow of $229.23 million.
| Operating Cash Flow | 230.29M |
| Capital Expenditures | -1.06M |
| Free Cash Flow | 229.23M |
| FCF Per Share | $3.85 |
Margins
Gross margin is 100.00%, with operating and profit margins of 46.05% and 52.76%.
| Gross Margin | 100.00% |
| Operating Margin | 46.05% |
| Pretax Margin | 53.45% |
| Profit Margin | 52.76% |
| EBITDA Margin | 46.35% |
| EBIT Margin | 46.05% |
| FCF Margin | 70.79% |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.78% |
| Shareholder Yield | -17.78% |
| Earnings Yield | 7.52% |
| FCF Yield | 10.10% |
Analyst Forecast
The average price target for PTGX is $54.63, which is 43.39% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $54.63 |
| Price Target Difference | 43.39% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 42.79% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 15.06 and a Piotroski F-Score of 4.
| Altman Z-Score | 15.06 |
| Piotroski F-Score | 4 |